Brief: Bluebird Bio Initiates Restructuring Intended To Optimize Cost Structure And Enable Quarterly Cash Flow Break-Even In The 2H25

bluebird bio

24/09/2024 12:02

Sept 24 (Reuters) - bluebird bio Inc  BLUE.O :
    * BLUEBIRD BIO INITIATES RESTRUCTURING INTENDED TO OPTIMIZE
COST
STRUCTURE AND ENABLE QUARTERLY CASH FLOW BREAK-EVEN IN THE
SECOND HALF OF 2025
    * BLUEBIRD BIO INC - ACTIONS INTENDED TO REDUCE CASH
OPERATING
EXPENSES BY APPROXIMATELY 20%
    * BLUEBIRD BIO INC - RESTRUCTURING TO REDUCE CASH OPERATING
EXPENSES BY 20%
    * BLUEBIRD BIO INC - 20% REDUCTION IN CASH OPERATING
EXPENSES
EXPECTED BY Q3 2025
    * BLUEBIRD BIO INC - WORKFORCE REDUCTION OF APPROXIMATELY
25%
    * BLUEBIRD BIO INC - TO FOCUS ON COMMERCIAL LAUNCHES OF
LYFGENIA,
ZYNTEGLO, AND SKYSONA

Source text for Eikon:  ID:nBwmSBZJa 
Further company coverage:  BLUE.O 

 ((Reuters.Briefs@thomsonreuters.com))